Healthcare provider profile · identity verified

Ioannis E. Eleftheriadis, MD

Internal Medicine · ANTIOCH, CA · NPI 1679651731

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	809	296
Lisinopril	Lisinopril	506	190
Amlodipine Besylate	Amlodipine Besylate	439	157
Tizanidine Hcl	Tizanidine Hcl	324	98
Famotidine	Famotidine	312	113
Levothyroxine Sodium	Levothyroxine Sodium	309	107
Losartan Potassium	Losartan Potassium	296	119
Atenolol	Atenolol	289	109
Fluticasone Propionate	Fluticasone Propionate	283	117
Meloxicam	Meloxicam	270	123
Hydrochlorothiazide	Hydrochlorothiazide	227	84
Metformin Hcl Er	Metformin Hcl	202	73
Simvastatin	Simvastatin	187	64
Tamsulosin Hcl	Tamsulosin Hcl	182	67
Allopurinol	Allopurinol	166	58
Trazodone Hcl	Trazodone Hcl	163	50
Alvesco	Ciclesonide	162	86
Metoprolol Tartrate	Metoprolol Tartrate	158	50
Furosemide	Furosemide	154	62
Gabapentin	Gabapentin	150	51
Albuterol Sulfate Hfa	Albuterol Sulfate	138	75
Glipizide	Glipizide	133	42
Metformin Hcl	Metformin Hcl	128	48
Pantoprazole Sodium	Pantoprazole Sodium	126	46
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	122	46
Ibuprofen	Ibuprofen	113	39
Terazosin Hcl	Terazosin Hcl	113	37
Sertraline Hcl	Sertraline Hcl	106	34
Metoprolol Succinate	Metoprolol Succinate	97	35
Prednisone	Prednisone	96	75
Lovastatin	Lovastatin	95	34
Alendronate Sodium	Alendronate Sodium	93	36
Triamcinolone Acetonide	Triamcinolone Acetonide	92	46
Duloxetine Hcl	Duloxetine Hcl	87	36
Potassium Chloride	Potassium Chloride	82	28
Cefadroxil	Cefadroxil	75	66
Finasteride	Finasteride	75	25
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	73	19
Jardiance	Empagliflozin	64	23
Omeprazole	Omeprazole	64	23
Lorazepam	Lorazepam	63	17
Montelukast Sodium	Montelukast Sodium	62	20
Pradaxa	Dabigatran Etexilate Mesylate	60	19
Rosuvastatin Calcium	Rosuvastatin Calcium	55	24
Colchicine	Colchicine	51	20
Humulin N	Insulin Nph Human Isophane	50	20
Veo Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	47	18
Wixela Inhub	Fluticasone Propion/Salmeterol	47	20
Sumatriptan Succinate	Sumatriptan Succinate	46	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	44	35
Bupropion Xl	Bupropion Hcl	43	11
Hydralazine Hcl	Hydralazine Hcl	40	15
Morphine Sulfate Er	Morphine Sulfate	40	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	39	13
Pravastatin Sodium	Pravastatin Sodium	39	15
Acyclovir	Acyclovir	38	17
Glipizide Er	Glipizide	38	14
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	37	15
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	37	suppressed
Carvedilol	Carvedilol	36	13
Boostrix Tdap	Diphth,pertuss(Acell),tet Vac	35	35
Doxycycline Monohydrate	Doxycycline Monohydrate	35	30
Spironolactone	Spironolactone	35	13
Warfarin Sodium	Warfarin Sodium	34	12
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	33	30
Fluoxetine Hcl	Fluoxetine Hcl	33	suppressed
Mirtazapine	Mirtazapine	32	11
Azelastine Hcl	Azelastine Hcl	31	12
Chlorthalidone	Chlorthalidone	30	12
Clopidogrel	Clopidogrel Bisulfate	30	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	30	suppressed
Spiriva Respimat	Tiotropium Bromide	30	13
Nabumetone	Nabumetone	29	12
Pioglitazone Hcl	Pioglitazone Hcl	28	suppressed
Citalopram Hbr	Citalopram Hydrobromide	27	11
Trospium Chloride	Trospium Chloride	27	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	26	suppressed
Bupropion Hcl Sr	Bupropion Hcl	26	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	26	12
Ozempic	Semaglutide	26	suppressed
Tramadol Hcl	Tramadol Hcl	26	suppressed
Fluocinonide	Fluocinonide	24	15
Propranolol Hcl	Propranolol Hcl	24	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	24	suppressed
Nitroglycerin	Nitroglycerin	23	13
Amoxicillin	Amoxicillin	22	15
Baclofen	Baclofen	22	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	22	suppressed
Metronidazole	Metronidazole	21	11
Clonidine Hcl	Clonidine Hcl	20	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	20	suppressed
Humulin 70-30	Insulin Nph Hum/Reg Insulin Hm	20	suppressed
Naproxen	Naproxen	20	suppressed
Veo Insulin Syringe	Syringe And Needle,insulin,1ml	19	suppressed
Midodrine Hcl	Midodrine Hcl	18	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	17	suppressed
Humulin R	Insulin Regular, Human	17	suppressed
Hydrocortisone	Hydrocortisone	17	11
Ondansetron Hcl	Ondansetron Hcl	17	suppressed
Humalog Kwikpen U-100	Insulin Lispro	16	suppressed
Ondansetron Odt	Ondansetron	16	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	15	13
Digoxin	Digoxin	15	suppressed
Humalog	Insulin Lispro	15	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	15	suppressed
Verapamil Er	Verapamil Hcl	15	suppressed
Clobetasol Propionate	Clobetasol Propionate	14	suppressed
Clonazepam	Clonazepam	14	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	14	suppressed
Temazepam	Temazepam	14	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	14	suppressed
Cefpodoxime Proxetil	Cefpodoxime Proxetil	13	12
Ezetimibe	Ezetimibe	13	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	13	11
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	13	suppressed
Azithromycin	Azithromycin	12	12
Levetiracetam	Levetiracetam	12	suppressed
Paroxetine Hcl	Paroxetine Hcl	12	suppressed
Veo Insulin Syringe	Syrge-Ndl,ins 0.3 Ml Half Mark	12	suppressed
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	11	11
Breyna	Budesonide/Formoterol Fumarate	11	suppressed
Fenofibrate	Fenofibrate	11	suppressed
Humulin 70/30 Kwikpen	Insulin Nph Hum/Reg Insulin Hm	11	suppressed
Nystatin-Triamcinolone	Nystatin/Triamcinolone Acet	11	suppressed
Pregabalin	Pregabalin	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error